» Articles » PMID: 16109714

Nuclear Factor of Activated T Cells C1 Induces Osteoclast-associated Receptor Gene Expression During Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Aug 20
PMID 16109714
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoclast differentiation from hematopoietic precursors is controlled by the tumor necrosis factor family member tumor necrosis factor-related activation-induced cytokine (TRANCE) via induction of various transcription factors, including nuclear factor of activated T cells (NFAT) c1. During osteoclast differentiation, NFATc1 is further activated via calcium signaling when costimulatory receptors expressed on osteoclast precursors, such as osteoclast-associated receptor (OSCAR), are stimulated. Here we show that NFATc1 expression precedes that of OSCAR during TRANCE-mediated osteoclastogenesis and that inhibition of NFATc1 by cyclosporin A abolishes TRANCE-induced OSCAR expression and subsequent osteoclast differentiation. Moreover, we show that the 1.0-kb promoter region of the OSCAR gene contains three potential NFATc1-binding sites. Induction of an OSCAR promoter-luciferase reporter is significantly increased when transiently transfected into 293T cells in combination with NFATc1 expression plasmid. Deletion and site-directed mutant constructs confirmed that NFATc1-binding sites are both functional and NFATc1-specific. Furthermore, NFATc1 synergistically activates an OSCAR reporter construct together with microphthalmia transcription factor and PU.1, transcription factors previously shown to be critical for osteoclast differentiation. In addition, a plasmid expressing constitutively active MAP kinase kinase 6 enhances the transactivation activity of NFATc1/microphthalmia transcription factor/PU.1 on the OSCAR promoter. Taken together, our results indicate that NFATc1 is an important transcription factor in the induction of OSCAR during osteoclastogenesis. Elucidation of NFATc1 as a transcription factor for OSCAR expression implies the presence of a positive feedback circuit of TRANCE-induced activation of NFATc1, involving NFATc1-mediated OSCAR expression and its subsequent activation of NFATc1, necessary for efficient differentiation of osteoclasts.

Citing Articles

Heme oxygenase-1: potential therapeutic targets for periodontitis.

Lv W, Hu S, Yang F, Lin D, Zou H, Zhang W PeerJ. 2024; 12:e18237.

PMID: 39430558 PMC: 11488498. DOI: 10.7717/peerj.18237.


Smoking and osteoimmunology: Understanding the interplay between bone metabolism and immune homeostasis.

Xie G, Huang C, Jiang S, Li H, Gao Y, Zhang T J Orthop Translat. 2024; 46:33-45.

PMID: 38765605 PMC: 11101877. DOI: 10.1016/j.jot.2024.04.003.


Estradiol induces bone osteolysis in triple-negative breast cancer via its membrane-associated receptor ERα36.

Cohen D, Dennis C, Deng J, Boyan B, Schwartz Z JBMR Plus. 2024; 8(5):ziae041.

PMID: 38644978 PMC: 11032217. DOI: 10.1093/jbmrpl/ziae041.


Exosome-targeted delivery of METTL14 regulates NFATc1 m6A methylation levels to correct osteoclast-induced bone resorption.

Yang J, Sun B, Wang Z, Li X, Gao J, Qian J Cell Death Dis. 2023; 14(11):738.

PMID: 37957146 PMC: 10643436. DOI: 10.1038/s41419-023-06263-4.


Material matters: exploring the interplay between natural biomaterials and host immune system.

Tripathi A, Zaki M, Al-Hussain S, Dubey B, Singh P, Rind L Front Immunol. 2023; 14:1269960.

PMID: 37936689 PMC: 10627157. DOI: 10.3389/fimmu.2023.1269960.